Direct evaluation of polarity of the ligand binding pocket in retinoid X receptor using a fluorescent solvatochromic agonist

Bioorg Med Chem Lett. 2023 Nov 15:96:129536. doi: 10.1016/j.bmcl.2023.129536. Epub 2023 Oct 30.

Abstract

High selectivity of small-molecule drug candidates for their target molecule is important to minimize potential side effects. One factor that contributes to the selectivity is the internal polarity of the ligand-binding pocket (LBP) in the target molecule, but this is difficult to measure. Here, we first confirmed that the retinoid X receptor (RXR) agonist 6-(ethyl(1-isobutyl-2-oxo-4-(trifluoromethyl)-1,2-dihydroquinolin-7-yl)amino)nicotinic acid (NEt-iFQ, 1) exhibits fluorescence solvatochromism, i.e., its Stokes shift depends on the polarity of the solvent, and then we utilized this property to directly measure the internal polarity of the RXRα-LBP. The Stokes shift of 1 when bound to the RXRα-LBP corresponded to that of 1 in chloroform solution. This finding is expected to be helpful for designing RXR-selective ligands. A similar approach should be appliable to evaluate the internal polarity of the LBPs of other receptors.

Keywords: Binding assay; Fluorescence; RXR; Solvatochromism.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Ligands
  • Retinoid X Receptors* / metabolism

Substances

  • Retinoid X Receptors
  • Ligands